Key facts
- It has raised $9.4M; the latest was Early Stage VC in Jan 2026.
- Notable investors include Midnight Venture Partners, The Kabech Fund, Tushara Dilanie.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Humanaut Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Humanaut Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Humanaut Health
Developer of a proactive medical testing and therapies intended to enhance the overall well-being of the patients. The company offers diagnostics, lifestyle factors, personalized coaching, and medicinal services, including peptides, hormones, and regenerative cell therapy interventions, enabling patients to get weight loss, sexual health, and chronic fatigue treatments.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2023
- Employees
- 48
- Website
- humanauthealth.com/
- Ownership
- Privately Held (backing)
Humanaut Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Humanaut Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Humanaut Health in its N-PORT filings yet. We sweep new filings monthly.